PDF) Cross-species higher sensitivities of FcγRIIIA/FcγRIV to afucosylated IgG for enhanced ADCC

Por um escritor misterioso

Descrição

PDF) Cross-species higher sensitivities of FcγRIIIA/FcγRIV to afucosylated  IgG for enhanced ADCC
Fc-engineered antibodies with immune effector functions completely abolished
PDF) Cross-species higher sensitivities of FcγRIIIA/FcγRIV to afucosylated  IgG for enhanced ADCC
Fc gamma receptors: glycobiology and therapeutic prospects
PDF) Cross-species higher sensitivities of FcγRIIIA/FcγRIV to afucosylated  IgG for enhanced ADCC
Cancers, Free Full-Text
PDF) Cross-species higher sensitivities of FcγRIIIA/FcγRIV to afucosylated  IgG for enhanced ADCC
Site-Specific Glycosylation Mapping of Fc Gamma Receptor IIIb from Neutrophils of Individual Healthy Donors
PDF) Cross-species higher sensitivities of FcγRIIIA/FcγRIV to afucosylated  IgG for enhanced ADCC
Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) in Cancer
PDF) Cross-species higher sensitivities of FcγRIIIA/FcγRIV to afucosylated  IgG for enhanced ADCC
Unique carbohydrate–carbohydrate interactions are required for high affinity binding between FcγRIII and antibodies lacking core fucose
PDF) Cross-species higher sensitivities of FcγRIIIA/FcγRIV to afucosylated  IgG for enhanced ADCC
The two primary forms of interaction between therapeutic IgGs and
PDF) Cross-species higher sensitivities of FcγRIIIA/FcγRIV to afucosylated  IgG for enhanced ADCC
FcγR dependent mechanisms of cytotoxic, agonistic, and neutralizing antibody activities: Trends in Immunology
PDF) Cross-species higher sensitivities of FcγRIIIA/FcγRIV to afucosylated  IgG for enhanced ADCC
Therapeutic antibodies for autoimmunity and inflammation
PDF) Cross-species higher sensitivities of FcγRIIIA/FcγRIV to afucosylated  IgG for enhanced ADCC
Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond
PDF) Cross-species higher sensitivities of FcγRIIIA/FcγRIV to afucosylated  IgG for enhanced ADCC
Enhancing FcγR-mediated antibody effector function during persistent viral infection
de por adulto (o preço varia de acordo com o tamanho do grupo)